Dr.Melaxin TX Tranexamic Acid Retinalsome Dual Eye Cream

"Two Problems Under the Eyes. One Formula That Addresses Both at Once."

Maya here. The under-eye area is where two separate skin concerns meet - and most eye creams are only solving one of them. Dark circles are a pigmentation issue: melanin accumulation, uneven tone, the kind of discolouration that brightening actives address. Fine lines are a structural issue: collagen loss, loss of elasticity, the concern that retinoids and peptides address. Finding a formula that handles both without compromising either is harder than it sounds, and it is the question I bring to every eye cream I review.

The Dr.Melaxin TX Tranexamic Acid Retinalsome Dual Eye Cream is built for exactly that. Two active formulas in a single dual-chamber dispenser - one with 3.5% Tranexamic Acid (Tran-EX-1) targeting melanin production and dark circles, one with 0.05% Retinalsome for collagen stimulation and wrinkle improvement. Both dispensed simultaneously with a single press. Niacinamide and Adenosine support tone-evening and firming as secondary actives. The brand confirms a 0.00 skin irritation score in human trials, which matters for a formula being applied daily to the sensitive eye area on dry, resistant skin like mine.

What is Retinalsome and how does it differ from standard retinol?

The delivery mechanism is what changes the efficacy. Retinol is effective but absorption-limited: it needs to convert through several enzymatic steps before it becomes active in the skin, and much of it is lost or degraded at the surface before reaching the target layer. Retinalsome is a liposome-encapsulated form of retinaldehyde - a retinoid one step closer to the active form retinoic acid than retinol. The liposome delivery vehicle protects the active from surface degradation and facilitates transport through the lipid barrier. The brand states Retinalsome is absorbed into the skin up to 11 times faster than standard retinol, with twice the potency via liposome technology. At 0.05% concentration, this is a precision dose for the sensitive periorbital area.

💛 Maya's Note: Retinalsome - a retinaldehyde ingredient encapsulated in a liposome delivery system. Retinaldehyde (retinal) is closer to the skin's active form of Vitamin A than retinol, requiring fewer conversion steps. The liposome encapsulation improves stability and penetration speed. Liposome technology - a delivery method using microscopic lipid spheres to encapsulate and transport active ingredients through the skin's barrier. Liposomes merge with the skin's own lipid layer, releasing actives more precisely at the target depth than surface-applied formulas.

Also Worth Considering:

What is tranexamic acid and why is 3.5% significant for dark circle treatment?

Tranexamic acid is a synthetic amino acid derivative originally used in medicine to control bleeding, later recognised for its potent melanin-inhibiting properties. It works by blocking the interaction between keratinocytes and melanocytes - specifically interrupting the plasmin pathway that triggers melanin production. For dark circles caused by hyperpigmentation under the eyes, this mechanism directly addresses the cause rather than masking it. The brand's proprietary Tran-EX-1 contains 3.5% tranexamic acid, which the brand positions as faster improvement compared to traditional brightening ingredients. The formula is described as gaining attention in the medical field for its brightening efficacy. Consistent use over at least one month - aligned with the skin's 28-day turnover cycle - is what the brand recommends before assessing results.

💛 Maya's Note: Tranexamic acid - a synthetic lysine derivative. Inhibits melanin production by blocking the plasmin pathway, which triggers pigment cells to produce melanin. Well-tolerated by sensitive skin and increasingly used in dermatological brightening treatments. Unlike Vitamin C, it does not oxidise and remains stable in formula. Keratinocyte-melanocyte interaction - the communication between skin cells and pigment-producing cells that triggers melanin release. Tranexamic acid interrupts this signalling process, reducing the amount of melanin produced at the site.

Also Worth Considering:

Is it safe to use the Retinalsome component daily in the eye area?

The brand has designed this for daily use and confirms a 0.00 skin irritation score from human trial testing. The 0.05% Retinalsome concentration is calibrated for periorbital use - lower than a full-face retinoid treatment and delivered via liposome for controlled release rather than direct surface contact. The brand recommends consistent daily use for the 28-day skin turnover cycle to complete before evaluating results. If used during the day, sunscreen is required afterward - retinoids increase UV sensitivity. For skin that is new to retinoids, every 2-3 day application is the brand's recommended starting frequency before moving to daily use.

How does the dual-chamber dispenser work and does it change the application method?

A single press of the "PRESS HERE" mechanism dispenses both formulas simultaneously in consistent proportions. The two actives - the tranexamic acid brightening formula and the Retinalsome anti-aging formula - are kept separate until dispensed, which preserves the stability of each active until point of use. This is a relevant packaging decision for a formula containing both a retinoid (light- and air-sensitive) and tranexamic acid (stable but best kept from cross-contamination with retinoid chemistry). Apply to the under-eye area as part of the nightly routine; if using in the morning, follow with SPF.

Worth Knowing

The Two Actives Are Working Through Different Mechanisms Simultaneously: Tranexamic acid interrupts melanin production at the cellular communication level, addressing the pigmentation cause of dark circles. Retinalsome stimulates collagen production and skin cell renewal, addressing the structural thinning that makes the under-eye area look shadowed and creased. Neither mechanism duplicates the other - they are working on different aspects of the same visible problem. The dual formula structure is not a marketing decision; it reflects the fact that dark circles and under-eye lines have different biological causes.

Niacinamide and Adenosine Are the Supporting Cast: Niacinamide regulates melanin transfer between skin cells for tone-evening alongside the tranexamic acid, and supports the skin barrier. Adenosine is a well-documented anti-aging active with evidence for reducing wrinkle depth through its role in cellular repair and collagen synthesis signalling - working alongside Retinalsome rather than duplicating it. The four actives address the problem from four complementary angles.

If You See Results in the First Week, That Is the Retinalsome: Faster surface improvement from the retinaldehyde's accelerated absorption and collagen activation may be visible earlier than the tranexamic acid's melanin-cycle result. The dark circle improvement from tranexamic acid builds over the 28-day skin turnover period. The two timelines are different - early improvement in texture and fine lines, slower but more fundamental improvement in tone and pigmentation.

Wondering Whether This Works for All Types of Dark Circles: Dark circles have multiple causes: hyperpigmentation (the tranexamic acid mechanism), vascular shadows from thin skin showing underlying blood vessels, and hollowness from fat pad loss with age. This formula directly addresses hyperpigmentation-type dark circles. For vascular or structural dark circles, the collagen support from Retinalsome and Adenosine helps with the thinning component over time, but a topical formula cannot address hollowness from volume loss. Understanding which type of dark circle is present helps set the right expectations.

3.5% tranexamic acid and liposome-delivered retinaldehyde in one dual-chamber formula - this is the eye cream built for melanin-rich skin managing pigmentation and collagen loss at the same time. Both concerns are real. A formula addressing both is what I was looking for. 💛